Improved molecular detection of ceftriaxone resistance in Neisseria gonorrhoeae in a reference laboratory setting
Journal of Antimicrobial Chemotherapy · 02.07.2026 · 81 (8)
DOI: 10.1093/jac/dkag211 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 07.07.2026. Verfasst von Anna Vickers und 7 weiteren Autor:innen. Beteiligte Einrichtung: STI Reference Laboratory, UK Health Security Agency, London, UK. Hauptthemen laut MEDLINE: Neisseria gonorrhoeae, Ceftriaxone, Anti-Bacterial Agents, Real-Time Polymerase Chain Reaction. Die Arbeit nennt 10 Literaturangaben. Gefördert von: UKHSA.
Abstract (Originalsprache)
Background
Ceftriaxone resistance threatens the last remaining empirical monotherapy for Neisseria gonorrhoeae. Ceftriaxone-resistant N. gonorrhoeae is rare in England, but cases are increasing. Rapid detection of ceftriaxone resistance, commonly conferred by mutations in the penA gene, facilitates rapid risk assessment and public health intervention including enhanced follow-up of cases.
Objectives
This study aimed to develop a real-time PCR for detection of the ceftriaxone resistance-associated penA-237.001 allele in N. gonorrhoeae, for use on both cultured isolates and residual clinical specimens.
Methods
A penA-237.001-specific assay was designed and evaluated using cultured isolates, residual clinical specimens and a broad exclusivity panel. Analytical sensitivity was assessed using serial dilutions of two penA-237.001-positive isolates prepared in specimen collection kit buffers and PBS.
Results
The assay demonstrated 100% specificity within the validation panel; all penA-237.001-positive isolates were correctly identified with no false-positive results. Detection was reliable to approximately 15 cfu/mL across all buffer types, with minimal cycle threshold variation.
Conclusions
This assay enables rapid and specific detection of penA-237.001 in cultured isolates and residual molecular specimens. Used alongside existing molecular assays, it offers enhanced early detection of ceftriaxone-resistant N. gonorrhoeae and supports timely public health action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- STI Reference Laboratory, UK Health Security Agency, London, UK.
- Formerly at UK Health Security Agency, London, UK.
- Blood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK.
ORCID-Profile: Penelope R Cliff, Helen Fifer, Sarah Alexander
Förderung
- UKHSA
Zitieren
APA
Vickers, A., Day, M., Doumith, M., Vivekanand, S., Cliff, P. R., Fifer, H., Alexander, S., & Pitt-Kendall, R. (2026). Improved molecular detection of ceftriaxone resistance in Neisseria gonorrhoeae in a reference laboratory setting. Journal of Antimicrobial Chemotherapy, 81(8). https://doi.org/10.1093/jac/dkag211
Vancouver
Vickers A, Day M, Doumith M, Vivekanand S, Cliff PR, Fifer H, et al. Improved molecular detection of ceftriaxone resistance in Neisseria gonorrhoeae in a reference laboratory setting. Journal of Antimicrobial Chemotherapy. 2026;81(8). doi:10.1093/jac/dkag211
BibTeX
@article{Vickers2026,
author = {Vickers, Anna and Day, Michaela and Doumith, Michel and Vivekanand, Sandhya and Cliff, Penelope R and Fifer, Helen and Alexander, Sarah and Pitt-Kendall, Rachel},
title = {Improved molecular detection of ceftriaxone resistance in Neisseria gonorrhoeae in a reference laboratory setting},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2026},
volume = {81},
number = {8},
doi = {10.1093/jac/dkag211}
}
EUVIMED